Prevalence and significance of risk enhancing biomarkers in the United States population at intermediate risk for atherosclerotic disease
Open Access
- 1 January 2022
- journal article
- research article
- Published by Elsevier in Journal of Clinical Lipidology
- Vol. 16 (1) , 66-74
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in AdultsJACC, 2014
- Measurement of waist circumference predicts coronary atherosclerosis beyond plasma adipokinesObesity, 2013
- Is Prediction of Cardiovascular Disease and All-cause Mortality Genuinely Driven by the Metabolic Syndrome, and Independently from its Component Variables? The Dubbo StudyHeart, Lung and Circulation, 2011
- Lipoprotein(a) as a cardiovascular risk factor: current statusEuropean Heart Journal, 2010
- Impact of A1C Screening Criterion on the Diagnosis of Pre-Diabetes Among U.S. AdultsDiabetes Care, 2010
- Associations of inflammatory markers with coronary artery calcification: Results from the Multi-Ethnic Study of AtherosclerosisAtherosclerosis, 2010
- C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysisThe Lancet, 2010
- Harmonizing the Metabolic SyndromeCirculation, 2009
- C-Reactive Protein as a Risk Factor for Coronary Heart Disease: A Systematic Review and Meta-analyses for the U.S. Preventive Services Task ForceAnnals of Internal Medicine, 2009
- The metabolic syndrome, diabetes, and subclinicalatherosclerosis assessed by coronary calciumJACC, 2003